Skip to Content

How is Sublocade administered?

Answers (1)

Official Answer by 22 Jan 2018

Sublocade (buprenorphine), from Indivior, is an extended-release, once-monthly injection for opioid use disorder (OUD). It is used in adult patients already on a stable dose of transmucosal (absorbed via mucus membrane) buprenorphine for a minimum of 7 days. Sublocade may reduce the burden of taking daily medication for patients in recovery. Sublocade should only be given by a healthcare provider once monthly by subcutaneous injection in the abdominal (stomach) region. Use only the syringe and safety needle included in the packaging.

What is the dose of Sublocade?

Sublocade is available in a prefilled syringe as a 100 mg per 0.5 mL or 300 mg per 1.5 mL strength of buprenorphine. The recommended dose of Sublocade following stabilization with transmucosal buprenorphine is 300 mg monthly for the first two months followed by a maintenance dose of 100 mg monthly. The provider may choose to increase the maintenance dose to 300 mg monthly for patients who tolerate the 100 mg dose, but do not have an acceptable clinical response, as shown by self-reported use of illicit opioids or positive opioid urine drug screens. free discount card

Further Information

Search for questions

Still looking for answers? Try searching for what you seek or ask your own question.

Frequently Asked Questions

What type of drug is Motegrity?

Updated 15 days ago 1 answerFAQ by

What disease is Elzonris (tagraxofusp-erzs) used to treat?

Updated 12 days ago 1 answerFAQ by

How do you use the ProAir Digihaler?

Updated 12 days ago 1 answerFAQ by

How many biosimilars have been approved in the United States?

Updated 11 days ago 1 answerFAQ by